Apicore LLC Announces the Submission of Their Drug Master File for Fondaparinux Sodium to the FDA

SOMERSET, N.J.--(BUSINESS WIRE)--Apicore LLC announced today that they filed a drug master file (DMF) for Fondaparinux Sodium active pharmaceutical ingredient (API) with the U.S. Food and Drug Administration (FDA) on June 28, 2010.